110 related articles for article (PubMed ID: 2323839)
1. Expression of the mdr3 gene in prolymphocytic leukemia: association with cyclosporin-A-induced increase in drug accumulation.
Nooter K; Sonneveld P; Janssen A; Oostrum R; Boersma T; Herweijer H; Valerio D; Hagemeijer A; Baas F
Int J Cancer; 1990 Apr; 45(4):626-31. PubMed ID: 2323839
[TBL] [Abstract][Full Text] [Related]
2. Expression of mdr1 and mdr3 multidrug-resistance genes in human acute and chronic leukemias and association with stimulation of drug accumulation by cyclosporine.
Herweijer H; Sonneveld P; Baas F; Nooter K
J Natl Cancer Inst; 1990 Jul; 82(13):1133-40. PubMed ID: 1972761
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of the mdr1 gene in blast cells from patients with acute myelocytic leukemia is associated with decreased anthracycline accumulation that can be restored by cyclosporin-A.
Nooter K; Sonneveld P; Oostrum R; Herweijer H; Hagenbeek T; Valerio D
Int J Cancer; 1990 Feb; 45(2):263-8. PubMed ID: 1968051
[TBL] [Abstract][Full Text] [Related]
4. Physical mapping, amplification, and overexpression of the mouse mdr gene family in multidrug-resistant cells.
Raymond M; Rose E; Housman DE; Gros P
Mol Cell Biol; 1990 Apr; 10(4):1642-51. PubMed ID: 1969609
[TBL] [Abstract][Full Text] [Related]
5. Multidrug resistance phenotype in patients with chronic lymphocytic leukemia as detected by immunofluorescence (FACS) and northern blot analysis.
Wulf G; Kluding H; Ho AD; Doerner M; Doehner H; Manegold C; Hunstein W
Leuk Res; 1994 Jul; 18(7):475-84. PubMed ID: 7912754
[TBL] [Abstract][Full Text] [Related]
6. Activity of P-glycoprotein in B-cell chronic lymphocytic leukemia determined by a flow cytometric assay.
Ludescher C; Hilbe W; Eisterer W; Preuss E; Huber C; Gotwald M; Hofmann J; Thaler J
J Natl Cancer Inst; 1993 Nov; 85(21):1751-8. PubMed ID: 8105101
[TBL] [Abstract][Full Text] [Related]
7. MDR3 P-glycoprotein, a phosphatidylcholine translocase, transports several cytotoxic drugs and directly interacts with drugs as judged by interference with nucleotide trapping.
Smith AJ; van Helvoort A; van Meer G; Szabo K; Welker E; Szakacs G; Varadi A; Sarkadi B; Borst P
J Biol Chem; 2000 Aug; 275(31):23530-9. PubMed ID: 10918072
[TBL] [Abstract][Full Text] [Related]
8. Modulation of multidrug resistance gene expression by dexamethasone in cultured hepatoma cells.
Zhao JY; Ikeguchi M; Eckersberg T; Kuo MT
Endocrinology; 1993 Aug; 133(2):521-8. PubMed ID: 8102093
[TBL] [Abstract][Full Text] [Related]
9. Xenobiotic transport differences in mouse mesangial cell clones expressing mdr1 and mdr3.
Ernest S; Bello-Reuss E
Am J Physiol; 1996 Mar; 270(3 Pt 1):C910-9. PubMed ID: 8638674
[TBL] [Abstract][Full Text] [Related]
10. Activation of multidrug resistance (P-glycoprotein) mdr3/mdr1a gene during the development of hepatocellular carcinoma in hepatitis B virus transgenic mice.
Kuo MT; Zhao JY; Teeter LD; Ikeguchi M; Chisari FV
Cell Growth Differ; 1992 Aug; 3(8):531-40. PubMed ID: 1356418
[TBL] [Abstract][Full Text] [Related]
11. High expression of the mdr3 multidrug-resistance gene in advanced-stage chronic lymphocytic leukemia.
Sonneveld P; Nooter K; Burghouts JT; Herweijer H; Adriaansen HJ; van Dongen JJ
Blood; 1992 Mar; 79(6):1496-500. PubMed ID: 1347708
[TBL] [Abstract][Full Text] [Related]
12. Genes amplified and overexpressed in human multidrug-resistant cell lines.
Van der Bliek AM; Baas F; Van der Velde-Koerts T; Biedler JL; Meyers MB; Ozols RF; Hamilton TC; Joenje H; Borst P
Cancer Res; 1988 Nov; 48(21):5927-32. PubMed ID: 2901906
[TBL] [Abstract][Full Text] [Related]
13. Expression of the MDR1 and MDR3 gene products in acute and chronic leukemias.
Arai Y; Masuda M; Sugawara I; Arai T; Motoji T; Tsuruo T; Oshimi K; Mizoguchi H
Leuk Res; 1997 Apr; 21(4):313-9. PubMed ID: 9150348
[TBL] [Abstract][Full Text] [Related]
14. Differential changes in genome structure and expression of the mdr gene family in multidrug-resistant murine erythroleukemia cell lines.
Fracasso PM; Slapak CA; Nair S; Modrak D; Draper MP; LeCerf JM; Levy SB
Oncol Res; 1997; 9(4):183-91. PubMed ID: 9268989
[TBL] [Abstract][Full Text] [Related]
15. Structural and functional characterization of the mouse multidrug resistance gene family.
Dhir R; Buschman E; Gros P
Bull Cancer; 1990; 77(11):1125-9. PubMed ID: 1980424
[TBL] [Abstract][Full Text] [Related]
16. Multidrug resistance (mdr1) gene expression in adult acute leukemias: correlations with treatment outcome and in vitro drug sensitivity.
Marie JP; Zittoun R; Sikic BI
Blood; 1991 Aug; 78(3):586-92. PubMed ID: 1859877
[TBL] [Abstract][Full Text] [Related]
17. Accumulation of lactosylceramide and overexpression of a PSC833-resistant P-glycoprotein in multidrug-resistant human sarcoma cells.
Aouali N; El Btaouri H; Dumontet C; Eddabra L; Malagarie-Cazenave S; Madoulet C; Morjani H
Oncol Rep; 2011 Apr; 25(4):1161-7. PubMed ID: 21318225
[TBL] [Abstract][Full Text] [Related]
18. Characterization of the human MDR3 P-glycoprotein and its recognition by P-glycoprotein-specific monoclonal antibodies.
Schinkel AH; Roelofs EM; Borst P
Cancer Res; 1991 May; 51(10):2628-35. PubMed ID: 1673638
[TBL] [Abstract][Full Text] [Related]
19. Induction of multidrug resistance in human cells by transient exposure to different chemotherapeutic drugs.
Chaudhary PM; Roninson IB
J Natl Cancer Inst; 1993 Apr; 85(8):632-9. PubMed ID: 8096875
[TBL] [Abstract][Full Text] [Related]
20. Expression of MDR1 and MDR3 gene products in paclitaxel-, doxorubicin- and vincristine-resistant cell lines.
Januchowski R; Wojtowicz K; Andrzejewska M; Zabel M
Biomed Pharmacother; 2014 Feb; 68(1):111-7. PubMed ID: 24140176
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
